Polynucleotide sequences encoding .delta.bcl-2 for preventing and treating autoimmune diseases
CA 2649821 C · Owner: Li, Fengchun · Inventors: Escher, Alan P.; Li, Fengchun
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A substance for preventing, delaying the onset of or treating one or more than one autoimmune disease the substance comprising a polynucleotide construct comprising a polynucleotide sequence encoding the pro-apoptotic protein BAX and encoding one or more than one autoantigen for the autoimmune disease. A method for preventing delaying the onset of or treating an autoimmune disease in a patient comprising selecting a patient who is susceptible to developing the autoimmune disease who is developing the autoimmune disease or who has the autoimmune disease and administering to the patient one or more than one dose of a polynucleotide construct comprising a polynucleotide sequence encoding the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 6, 2003 and granted September 20, 2016. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 6, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 6, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.